Answers are grounded in this paper and cite their sources.
Review highlights safe strategies for managing vestibular disorders like vertigo during pregnancy, indicating the need for careful medication use and collaborative care.
Vestibular disorders such as vestibular migraine (VM), benign paroxysmal positional vertigo (BPPV), Ménière's disease (MD), persistent postural-perceptual dizziness (PPPD), and vestibular neuritis (VN) are not uncommon among women of reproductive age and may occur or worsen during pregnancy. However, the management of these disorders during gestation is complicated by physiological changes, the limited safety data on many medications, and ethical constraints in clinical research involving pregnant individuals. This review focuses on the therapeutic strategies employed in managing vestibular disorders during pregnancy, highlighting pharmacological and non-pharmacological interventions, evidence-based approaches, current limitations, and areas requiring further research. Emphasis is placed on safety profiles, individualized care, and interdisciplinary collaboration to optimize maternal health while minimizing fetal risk.
No takes yet. Share an insight, caveat, or question.
Castillo‐Bustamante et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: